🇺🇸 FDA
Patent

US 11844805

Formulations of testosterone and methods of treatment therewith

granted A61KA61K31/568A61K31/5685

Quick answer

US patent 11844805 (Formulations of testosterone and methods of treatment therewith) held by The Board of Regents of the University of Texas System expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/568, A61K31/5685, A61K31/573, A61K45/06